Body Mass Index is a Useful Predictor of Prognosis After Left Ventricular Assist System Implantation

Journal of Heart and Lung Transplantation

Volumn 28, Issue 5, 2009, Pages 428-433

  Mano, Akiko ^a   Fujita, Kiyoharu ^b   Uenomachi, Kaori ^b   Kazama, Keiichi ^b   Katabuchi, Mayumi ^b   Wada, Kyoichi ^b   Terakawa, Nobue ^b   Arai, Koji ^b   Hori, Yumiko ^b   Hashimoto, Syuji ^b   Nakatani, Takeshi ^b   Kitamura, Soichiro ^b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ASSIST DEVICE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SEPSIS;

ADOLESCENT; ADULT; BODY MASS INDEX; C-REACTIVE PROTEIN; CHILD; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEPSIS; SURVIVAL RATE;

EID: 65349118286     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.12.020     Document Type: Article

References (30)

1. Peeters A., Barendregt J.J., Willekens F., et al. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 138 (2003) 24-32
2. Mozaffarian D., Kamineni A., Prineas R.J., et al. Metabolic syndrome and mortality in older adults: the Cardiovascular Health Study. Arch Intern Med 168 (2008) 969-978
3. Kressel G, Trunz B, Bob A, et al. Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk. Atherosclerosis (in press).
4. Despres J.P., Lemieux I., Bergeron J., et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 28 (2008) 1039-1049
5. Flegal K.M., Graubard B.I., Williamson D.F., et al. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 298 (2007) 2028-2037
6. Calle E.E., Thun M.J., Petrelli J.M., et al. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341 (1999) 1097-1105
7. Manson J.E., Willett W.C., Stampfer M.J., et al. Body weight and mortality among women. N Engl J Med 333 (1995) 677-685
8. Horwich T.B., Fonarow G.C., Hamilton M.A., et al. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 38 (2001) 789-795
9. Curtis J.P., Selter J.G., Wang Y., et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 165 (2005) 55-61
10. Lavie C.J., Osman A.F., Milani R.V., et al. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol 91 (2003) 891-894
11. Fonarow G.C., Srikanthan P., Costanzo M.R., et al. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 153 (2007) 74-81
12. Cicoria M., Maggioni A.P., Latini R., et al. Body mass index, prognosis and mode of death in chronic heart failure: results from the Valsartan Heart Failure Trial. Eur J Heart Fail 9 (2007) 397-402
13. Rose E.A., Gelings A.C., Moskowitz A.J., et al. Long-term use of a left ventricular assist device for end stage heart failure. N Engl J Med 345 (2001) 1435-1443
14. Lietz K., John R., Burke E.A., et al. Pretransplant cachexia and morbid obesity are predictors of increased mortality after heart transplantation. Transplantation 72 (2001) 277-283
15. Costanzo M.R., Augustine S., Bourge R., et al. Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 92 (1995) 3593-3612
16. Grady K.L., Naftel D.C., Costanzo M.R., et al. Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality?: a multi-institutional study of preoperative weight-height indices. J Heart Lung Transplant 18 (1999) 750-763
17. Rossano J.W., Grenier M.A., Dreyer W.J., et al. Effect of body mass index on outcome in pediatric heart transplant patients. J Heart Lung Transplant 26 (2007) 718-723
18. Butler J., Howser R., Portner P.M., et al. Body mass index and outcomes after left ventricular assist device placement. Ann Thorac Surg 79 (2005) 66-73
19. Piccione Jr. W. Left ventricular assist device implantation: short and long-term surgical complications. J Heart Lung Transplant 19 suppl (2000) S89-S94
20. Salzberg S., Lachat M., Zund G., et al. Left ventricular assist device as bridge to heart transplantation-lessons learned with the MicroMed DeBakey axial blood flow pump. Eur J Cardiothorac Surg 24 (2003) 113-118
21. Rauchhaus M., Coats A.J., and Anker S.D. The endotoxin-lipoprotein hypothesis. Lancet 356 (2000) 930-933
22. Mustafa I., and Leverve X. Metabolic and nutritional disorders in cardiac cachexia. Nutrition 17 (2001) 756-760
23. Anker S.D., and Coats A.J. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Chest 115 (1999) 836-847
24. Weber M.A., Neutel J.M., and Smith D.H. Contrasting clinical properties and exercise responses in obese and lean hypertensive patients. J Am Coll Cardiol 37 (2007) 169-174
25. Anker S.D., Negassa A., Coats A.J., et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 361 (2003) 1077-1083
26. Oreopoulos A., Padwal R., Kalantar-Zadeh K., et al. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 156 (2008) 13-22
27. Feldman A., Combes A., Wagner D., et al. The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol 35 (2000) 537-544
28. Van-Zee K.J., Kohno T., Fischer E., et al. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci USA 89 (1992) 4845-4849
29. Mohamed-Ali V., Goodrick S., Bulmer K., et al. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol 277 (1999) E971-E975
30. Dovos C.H., Doehner W., Rauchhaus M., et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 9 (2003) 29-35